• Miscellaneous urogenital disorders

Tarpeyo Generic Name & Formulations

General Description

Budesonide 4mg; del-rel caps.

Pharmacological Class


How Supplied


Generic Availability


Tarpeyo Indications


To reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk of rapid disease progression, generally a urine protein-to-creatinine ratio (UPCR) ≥1.5 g/g.

Tarpeyo Dosage and Administration


Swallow whole. Take in the AM at least 1hr before a meal. 16mg once daily. Treat for 9 months. When discontinuing treatment, reduce dose to 8mg once daily for the last 2 weeks.


Not established.

Tarpeyo Contraindications

Not Applicable

Tarpeyo Boxed Warnings

Not Applicable

Tarpeyo Warnings/Precautions


Avoid in active or quiescent tuberculosis, untreated fungal, bacterial, systemic viral or parasitic infections, or ocular herpes simplex. If exposed to chickenpox or measles, consider immune globulin or antiviral prophylactic therapies. Supplement with systemic corticosteroids in surgery or other stress situations. Monitor for adrenal axis suppression when discontinuing therapy or switching between corticosteroids. Hypertension. Diabetes. Osteoporosis. Peptic ulcer. Glaucoma. Cataracts. Moderate hepatic impairment: monitor for hypercorticism. Severe hepatic impairment: avoid. Elderly. Pregnancy. Nursing mothers.

Tarpeyo Pharmacokinetics

See Literature

Tarpeyo Interactions


Avoid grapefruit juice. May be potentiated by potent CYP3A4 inhibitors (eg, ketoconazole, itraconazole, ritonavir, indinavir, saquinavir, erythromycin, cyclosporine); avoid. May decrease immune response to some vaccines.

Tarpeyo Adverse Reactions

Adverse Reactions

Hypertension, peripheral edema, muscle spasms, acne, dermatitis, weight increase, dyspnea, face edema, dyspepsia, fatigue, hirsutism; hypercorticism.

Tarpeyo Clinical Trials

See Literature

Tarpeyo Note

Not Applicable

Tarpeyo Patient Counseling

See Literature